291 related articles for article (PubMed ID: 8917700)
61. Pharmacokinetics of whole IgG equine antivenom: comparison between normal and envenomed rabbits.
Quesada L; Sevcik C; Lomonte B; Rojas E; Gutiérrez JM
Toxicon; 2006 Sep; 48(3):255-63. PubMed ID: 16863656
[TBL] [Abstract][Full Text] [Related]
62. Body distribution of Tityus serrulatus scorpion venom in mice and effects of scorpion antivenom.
Revelo MP; Bambirra EA; Ferreira AP; Diniz CR; Chávez-Olórtegui C
Toxicon; 1996 Oct; 34(10):1119-25. PubMed ID: 8931252
[TBL] [Abstract][Full Text] [Related]
63. Effect of Indian red scorpion (Mesobuthus tamulus concanesis, Pocock) venom on thyroxine and triiodothyronine in experimental acute myocarditis and its reversal by species specific antivenom.
Murthy KR; Zare MA
Indian J Exp Biol; 1998 Jan; 36(1):16-21. PubMed ID: 9536646
[TBL] [Abstract][Full Text] [Related]
64. Safety of intravenous equine F(ab')2: insights following clinical trials involving 1534 recipients of scorpion antivenom.
Boyer L; Degan J; Ruha AM; Mallie J; Mangin E; Alagón A
Toxicon; 2013 Dec; 76():386-93. PubMed ID: 23916602
[TBL] [Abstract][Full Text] [Related]
65. Combination of two antibody fragments F(ab')(2)/Fab: an alternative for scorpion envenoming treatment.
Sami-Merah S; Hammoudi-Triki D; Martin-Eauclaire MF; Laraba-Djebari F
Int Immunopharmacol; 2008 Oct; 8(10):1386-94. PubMed ID: 18687300
[TBL] [Abstract][Full Text] [Related]
66. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
Sobol E; Bialer M
Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
[TBL] [Abstract][Full Text] [Related]
67. Ability of horse anti-Tityus discrepans F(ab')2 ELISA assay to recognize Tityus discrepans venom toxins.
Díaz P; D'Suze G; Sevcik C
Toxicon; 2014 Sep; 88():88-92. PubMed ID: 24932739
[TBL] [Abstract][Full Text] [Related]
68. Pharmacokinetics and bioavailability of nimesulide in goats.
Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC
J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902
[TBL] [Abstract][Full Text] [Related]
69. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
Valet SB; Schwartz RH; Brooks JG
Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
[TBL] [Abstract][Full Text] [Related]
70. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
71. General biochemical and immunological characterization of the venom from the scorpion Tityus trivittatus of Argentina.
de Roodt AR; Coronas FI; Lago N; González ME; Laskowicz RD; Beltramino JC; Saavedra S; López RA; Reati GJ; Vucharchuk MG; Bazán E; Varni L; Salomón OD; Possani LD
Toxicon; 2010; 55(2-3):307-19. PubMed ID: 19706301
[TBL] [Abstract][Full Text] [Related]
72. Pharmacokinetics and disposition of clenbuterol in the horse.
Soma LR; Uboh CE; Guan F; Moate P; Luo Y; Teleis D; Li R; Birks EK; Rudy JA; Tsang DS
J Vet Pharmacol Ther; 2004 Apr; 27(2):71-7. PubMed ID: 15096103
[TBL] [Abstract][Full Text] [Related]
73. Development of protective agent against Hottentotta saulcyi venom using camelid single-domain antibody.
Darvish M; Behdani M; Shokrgozar MA; Pooshang-Bagheri K; Shahbazzadeh D
Mol Immunol; 2015 Dec; 68(2 Pt B):412-20. PubMed ID: 26468036
[TBL] [Abstract][Full Text] [Related]
74. Pharmacokinetics of the Sri Lankan hump-nosed pit viper (Hypnale hypnale) venom following intravenous and intramuscular injections of the venom into rabbits.
Tan CH; Sim SM; Gnanathasan CA; Fung SY; Tan NH
Toxicon; 2014 Mar; 79():37-44. PubMed ID: 24412778
[TBL] [Abstract][Full Text] [Related]
75. Camelid antivenom development and potential in vivo neutralization of Hottentotta saulcyi scorpion venom.
Darvish M; Ebrahimi SA; Shahbazzadeh D; Bagheri KP; Behdani M; Shokrgozar MA
Toxicon; 2016 Apr; 113():70-5. PubMed ID: 26809016
[TBL] [Abstract][Full Text] [Related]
76. Scorpion envenomation and serotherapy in Morocco.
Ghalim N; El-Hafny B; Sebti F; Heikel J; Lazar N; Moustanir R; Benslimane A
Am J Trop Med Hyg; 2000 Feb; 62(2):277-83. PubMed ID: 10813485
[TBL] [Abstract][Full Text] [Related]
77. Heminecrolysin, a potential immunogen for monospecific antivenom production against Hemiscorpius lepturus scorpion.
Borchani L; Sassi A; Ben Yekhlef R; Safra I; El Ayeb M
Toxicon; 2011 Dec; 58(8):681-8. PubMed ID: 21967811
[TBL] [Abstract][Full Text] [Related]
78. Comparative analyses and implications for antivenom serotherapy of four Moroccan scorpion Buthus occitanus venoms: Subspecies tunetanus, paris, malhommei, and mardochei.
Emerich BL; De Lima ME; Martin-Eauclaire MF; Bougis PE
Toxicon; 2018 Jul; 149():26-36. PubMed ID: 28712915
[TBL] [Abstract][Full Text] [Related]
79. The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration.
Chay S; Woods WE; Rowse K; Nugent TE; Blake JW; Tobin T
Drug Metab Dispos; 1983; 11(3):226-31. PubMed ID: 6135581
[TBL] [Abstract][Full Text] [Related]
80. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
Ferraiolo BL; Moore JA; Crase D; Gribling P; Wilking H; Baughman RA
Drug Metab Dispos; 1988; 16(2):270-5. PubMed ID: 2898346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
